Case File
efta-01762970DOJ Data Set 10OtherEFTA01762970
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-01762970
Pages
5
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From:
McCaffrey, Carlyn
Sent:
Monday, February 11, 2013 2:17 AM
To:
Jeffrey Epstein
Subject:
RE: Re:
Where can=you get prices? I didn't think there were any traded 10-year call op=ions. What kind of price do you think
there would be for a 10-year c=ll on with a strike price equal to a stock's current market price?
Carlyn S. McCaffreeb> Partner
McDermott Will & Emer LLP 340 Madison Ave=ue, New York, NY 10173
I =a href="http://www.mwe.com">www.mwe.com
Fr=m: Jeffrey Epstein [mailto:[email protected]
Sent: Sund=y, February 10, 2013 6:29 PM
To: McCaffrey, Carlyn
Subject= Re:
=/p>
we can actuallyl ge= prices. we could make them european, only excericable =t expiration. etc. yes
On Su=, Feb 10, 2013 at 7:24 PM, McCaffrey, Carlyn
wrote:=/p>
I know that the relationship between the=strike price and current value are important factors in determining the pr=ce
of an option but aren't the length of the option and the volatility of =he stock also very important? If there are no 10
year publicly trade= options we would have to get an appraisal.
Are you sure that a purchase be LB of the partner=hip interest followed by a sale by him of a call isn't caught by 16b?
<=r>On Feb 10, 2013, at 11:37 AM, "Jeffrey Epstein" <[email protected]&=t; wrote:
1.&=bsp; according to the strike, price, 2. the economic effect can be m=nged in the document. 3, security wise
lock up is only concern =as long as it happens near the same time and is not deep in the money,&nbs=; 4, the price of
the option reflects the risk of that,</=>
On Sun, Feb 10, 2013 at 12:27 PM, McCaffrey, Ca=Iyn
wrote:
What w=uld the price of a 10 year option be?
EFTA_R1_00068684
EFTA01762970
Although he =an buy the PS interest , the call will have to be on the stock itself.
=p class=MsoNormal>Your structure bypasses 2703 because LB will never del=ver the stock pursuant to the
option. The economic effect, however, is the=same. That's why some think it doesn't work.
What =re the securities law consequences of LB buying stock and the selling a ca=l?
Does the purchas=r of a publicly traded call risk the possibility that the stock value will=not increase because all
the growth will be paid out in dividends?
=n Feb 10, 2013, at 10:36 AM, "Jeffrey Epstein" <[email protected]>=wrote:
good f=rst try, yes call options are publicly traded, we would do fiv= to ten year terms„ he could
purchase the partner ship interest i =uess, valuation the issue , he could decide on how much,=we wouldn't need to
bypass 2703, the stock would be full value but t=ere would be an liability against it , which could not be ignored. &n=sp;
he would not need much money to live as he would have the full d=vidends.
On Sun Feb 10 2013 at 1=:16 AM, McCaffrey, Carlyn
> wrote:
I agree (although at least one of my partners does not) that you c=n avoid the reach of section 2703 with
a cash settled option.<=o:p>
How would =e price the option? Are call options on the stock publicly tra=ed? How are dividends
treated under the normal stock option?<=:p>
Here=s how I understand your proposal.
&nbs=;
Step 1- LB buys stock from Trust (T)=for $1B. LB issues a $18 note to T bearing interest at X=. and
secured by a lien on his art. We need to discuss what X should=be. We also need to think about the mechanics which
are made a littl= difficult by the fact that the stock is held in a partnership. We a=so need to think about the fact that
much of his art is already subject to=a lien held by US Trust.
Step #2 - LB sells a 2 year call to T. =he price for the call is $.1B (obviously, a rough estimate); the strike
pr=ce is the current market price.
=o:p>
2
EFTA_R1_00068685
EFTA01762971
Step=5 - LB sells another 2 year call to T, etc.
<=pan style=lont-size:11.0pt;font-family:"Calibri","sans-serir;color:#1F=97D1>
There are no income tax con=equences because of the grantor trust rules.
<=pan style=lont-size:11.0pt;font-family:"Calibri","sans-serir;colorlf1F=97D5
What are the securities law=consequences? Are any of these transactions covered by Rule 16b?&nbs=;
Do these transactions have to be reported?
apan style&font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F=.97D.>
Is this what you had in min=?
<=pan style=lont-size:11.0pt;font-family:"Calibri","sans-serir;color:141F=97D.>
Car=yn S. McCaffrey I Partner
McDermott Will & Emery L=P 1340 Madison Avenue, New York, NY 10173
www.m=e.com <http://www.mwe.com>
From: Jeffrey Epstein Imailto:[email protected] <mailto:[email protected]> I
Sent: </=> Saturday, February 09, 2013 8:11 PM
To: McCaffrey, Carlyn
<=>Subject:
i have reviewed the 2703 regs, i don't see the issue, if the=trust buys an option, at market, today and
the stock goes up, =he stock gets valued at the fair market, but the cash settled option come= due reducing the value
of the estate. , bringing the same net result.&nbs=; and even better if debra gets the stock with a step up, = what am i
misssing?
The information contained in this communication is
co=fidential, may be attorney-client privileged, may
constitute inside inf=rmation, and is intended only for
3
EFTA_R1_00068686
EFTA01762972
the use of the addressee. It is the p=operty of
Jeffrey Epstein
Unauthorized use, disclosure or copying o= this
communication or any part thereof is strictly prohibited
and m=y be unlawful. If you have received this
communication in error, please=notify us immediately by
return e-mail or by e-mail to [email protected], anddestroy this communication and all copies
thereof,
including all attac=ments. copyright -all rights reserved
IRS Circular 230 Disclosure: To comp=y with requirements imposed by the IRS, we inform you that any
U.S. federa= tax advice contained herein (including any attachments), unless specifica=ly stated otherwise, is not
intended or written to be used, and cannot be =sed, for the purposes of (i) avoiding penalties under the Internal
Revenue=Code or (ii) promoting, marketing or recommending to another party any tra=saction or matter herein.
This message is a PRIVILEGED AND=CONFIDENTIAL communication. This message and all attachments
are a private=communication sent by a law firm and may be confidential or protected by p=ivilege. If you are not the
intended recipient, you are hereby notified th=t any disclosure, copying, distribution or use of the information containe=
in or attached to this message is strictly prohibited. Please notify the =ender of the delivery error by replying to this
message, and then delete i= from your system. Thank you.
=r>
Please visit http:=/www.mwe.com/ <http://www.mwe.com/> for more information about our
Firm.</=>
*****
*•**,
The information conta=ned in this communication is
confidential, may be attorney-client privi=eged, may
constitute inside information, and is intended only for
th= use of the addressee. It is the property of
Jeffrey Epstein
Unauth=rized use, disclosure or copying of this
communication or any part ther=of is strictly prohibited
and may be unlawful. If you have received thi=
communication in error, please notify us immediately by
return e-ma=l or by e-mail to [email protected] <mailto:[email protected]> , and
destroy this communication and all cop=es thereof,
including all attachments. copyright -all rights reserved
4
EFTA_R1_00068687
EFTA01762973
The information contained in this communication is
confidential= may be attorney-client privileged, may
constitute inside information, =nd is intended only for
the use of the addressee. It is the property of=br>Jeffrey Epstein
Unauthorized use, disclosure or copying of this
=ommunication or any part thereof is strictly prohibited
and may be unla=ful. If you have received this
communication in error, please notify us=immediately by
return e-mail or by e-mail to [email protected] <mailto:[email protected]> , and
destroy =his communication and all copies thereof,
including all attachments. co=yright -all rights reserved
<= class=MsoNormal>
The information contained =n this communication is
confidential, may be attorney-client privileged= may
constitute inside information, and is intended only for
the use=of the addressee. It is the property of
Jeffrey Epstein
Unauthorize= use, disclosure or copying of this
communication or any part thereof i= strictly prohibited
and may be unlawful. If you have received this
=ommunication in error, please notify us immediately by
return e-mail or=by e-mail to [email protected] <mailto:[email protected]> , and
destroy this communication and all copies t=ereof,
including all attachments. copyright -all rights reserved</=:p>
5
EFTA_R1_00068688
EFTA01762974
Technical Artifacts (6)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
[email protected]Email
[email protected]Email
[email protected]Email
[email protected]Email
[email protected]URL
http://www.mwe.comRelated Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.